Metropolitan Life Insurance CO Accelerate Diagnostics, Inc Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$7.04 - $11.7 $60,163 - $99,988	-8,546 Closed	0 $0
Q3 2020 Jun 26, 2023	BUY	$9.98 - $18.04 $85,289 - $154,169	8,546 New	8,546 $91,000
Q2 2020 Jun 26, 2023	BUY	$7.49 - $15.16 $64,009 - $129,557	8,546 New	8,546 $129,000
Q1 2020 Jul 12, 2023	BUY	$4.62 - $18.74 $39,482 - $160,152	8,546 New	8,546 $71,000
Q1 2020 Mar 30, 2023	BUY	$4.62 - $18.74 $3,210 - $13,024	695 Added 8.85%	8,546 $71,000
Q1 2020 May 15, 2020	BUY	$4.62 - $18.74 $3,210 - $13,024	695 Added 8.85%	8,546 $71,000
Q4 2019 Jul 12, 2023	BUY	$14.6 - $18.13 $114,624 - $142,338	7,851 New	7,851 $132,000
Q4 2019 Mar 30, 2023	SELL	$14.6 - $18.13 $12,789 - $15,881	-876 Reduced 10.04%	7,851 $132,000
Q4 2019 Feb 14, 2020	SELL	$14.6 - $18.13 $12,789 - $15,881	-876 Reduced 10.04%	7,851 $133,000
Q3 2019 Jul 12, 2023	BUY	$16.62 - $23.92 $145,042 - $208,749	8,727 New	8,727 $162,000
Q2 2019 Jul 12, 2023	BUY	$17.79 - $22.88 $155,253 - $199,673	8,727 New	8,727 $199,000
Q1 2019 Jul 13, 2023	BUY	$11.76 - $22.15 $102,629 - $193,303	8,727 New	8,727 $183,000
Q1 2019 Mar 30, 2023	BUY	$11.76 - $22.15 $102,629 - $193,303	8,727 New	8,727 $183,000
Q1 2019 May 16, 2019	SELL	$11.76 - $22.15 $72,159 - $135,912	-6,136 Reduced 41.28%	8,727 $183,000
Q1 2019 May 15, 2019	BUY	$11.76 - $22.15 $72,159 - $135,912	6,136 Added 70.31%	14,863 $953,000
Q4 2018 Jul 13, 2023	BUY	$10.42 - $21.94 $90,935 - $191,470	8,727 New	8,727 $100,000
Q4 2018 Feb 14, 2019	BUY	$10.42 - $21.94 $69,855 - $147,085	6,704 Added 331.39%	8,727 $100,000
Q3 2018 Jul 13, 2023	BUY	$20.4 - $24.6 $178,030 - $214,684	8,727 New	8,727 $200 Million
Q3 2018 Nov 14, 2018	SELL	$20.4 - $24.6 $136,761 - $164,918	-6,704 Reduced 76.82%	2,023 $46,000
Q4 2017 Feb 15, 2018	SELL	$18.0 - $30.0 $145,062 - $241,770	-8,059 Reduced 48.01%	8,727 $229,000
Q2 2017 Aug 14, 2017	BUY	N/A	16,786	16,786 $459,000

Others Institutions Holding AXDX

# of Institutions

Shares Held

549K

Call Options Held

Put Options Held

View Full List

About Accelerate Diagnostics, Inc

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

More about AXDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account